GlassScriptPhysician profile
Amber Burns
NPI 1942963590
$621.57
in general payments reported to CMS, 2019-2025
13 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $31.15 · 2023: $124 · 2024: $315 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $590.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $121.83 | 2024 | Arexvy |
| Organon LLC | $77.66 | 2023-2025 | Nexplanon |
| Astellas Pharma US INC | $61.52 | 2023-2025 | Veozah |
| Biogen, INC. | $60.65 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $54.49 | 2024-2025 | Paragard T 380a |
| Daiichi Sankyo INC. | $49.76 | 2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $43.99 | 2022-2024 | |
| Exeltis, USA INC. | $42.32 | 2023 | Slynd |
| Vertex Pharmaceuticals Incorporated | $39.35 | 2024-2025 | |
| Shield Therapeutics INC | $22.81 | 2023 | Accrufer |
| Aspira Women'S Health INC | $16.78 | 2024 | Ova1 |
| Abbvie INC. | $15.51 | 2022 | |
| Hologic Sales and Service, LLC | $14.90 | 2024 | Thinprep 2000 Processor, Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.